![]() |
Volumn 9, Issue 2, 2013, Pages 73-77
|
Analyzing the affordable care act: Essential health benefits and implications for oncology
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PRESCRIPTION DRUG;
ARTICLE;
CANCER DIAGNOSIS;
COST;
DRUG CLASSIFICATION;
DRUG COST;
GOVERNMENT;
HEALTH CARE ACCESS;
HEALTH CARE POLICY;
HEALTH INSURANCE;
HEALTH MAINTENANCE ORGANIZATION;
HUMAN;
MEDICAID;
MEDICARE;
ONCOLOGY;
REIMBURSEMENT;
UNITED STATES;
ANTINEOPLASTIC AGENTS;
HUMANS;
INSURANCE COVERAGE;
INSURANCE, PHARMACEUTICAL SERVICES;
MEDICAL ONCOLOGY;
NEOPLASMS;
PATIENT PROTECTION AND AFFORDABLE CARE ACT;
UNITED STATES;
|
EID: 84882777963
PISSN: 15547477
EISSN: 1935469X
Source Type: Journal
DOI: 10.1200/JOP.2012.000881 Document Type: Article |
Times cited : (12)
|
References (11)
|